ACE2 and COVID-19: Adults previously infected had higher S-RBD concentrations, ACE2 binding inhibiting activity and antibody avidity index after one COVID-19 vaccine compared to SARS-CoV-2 naïve participants post-vaccination with homologous series of mRNA-1273, BNT162b2, or ChAdOx1-S25.